360iResearch Logo
Global Biosimilars Market
Report Code: MRR-17D6591 | Publishing Date: May 2020 | Number of Pages: 204
Global Biosimilars Market | Market Research Report | Cumulative Impact of COVID-19

Market Dynamics:

The factors attributing to the growth of the market are growing demands of pharmaceutical drugs, supportive government initiative and awareness creating programs in the developing economies, growing pressure to reduce healthcare expenditure, lower cost biosimilars drugs than original biologics, and expiration of major patents during the forecast period. However, some factors such as reluctance of physicians to prescribe biosimilars and unawareness among patients and preference for brand may hinder the market growth. The Biosimilars Market is expected to showcase the opportunities such as new indications and patent expiry of biologic products, emergence of bio-betters drugs, and potential in emerging markets. In the near future market may face the possible challenges in the growth due to stringent regulatory requirements adversely affecting investment in the biosimilars market and high investment required for research and development. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Biosimilars Market.

Market Segmentation & Coverage:

The research report categorizes the Biosimilars Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Indication, the Biosimilars Market is studied across Autoimmune Diseases, Blood Disorders, Chronic Diseases, Growth Hormone Deficiency, Infectious Diseases, and Oncology.

On the basis of Product, the Biosimilars Market is studied across Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, and Recombinant Peptides. The Recombinant Glycosylated Proteins further studied across Erythropoietin, Follitropin, and Monoclonal Antibodies. The Recombinant Non-Glycosylated Proteins further studied across Granulocyte Colony-Stimulating Factor, Insulin, Interferons, and Recombinant Human Growth Hormone. The Recombinant Peptides further studied across Calcitonin and Glucagon.

On the basis of Manufacturing, the Biosimilars Market is studied across Contract Manufacturing and In-House Manufacturing.

On the basis of Geography, the Biosimilars Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The Biosimilars Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biosimilars Market including AMEGA Biotech S.A., Amgen Inc., Apotex Inc., Biogen Inc., Biogen Inc., Biosidus S.A., Bioton S.A., Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories Limited, Innovent Biologics, Inc., JHL Biotech, Inc., LG Chem, Ltd., Merck Sharp & Dohme Corp., Mylan N.V., Pfizer Inc., and Sandoz International GmbH.

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Biosimilars Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Biosimilars Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Biosimilars Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Biosimilars Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Biosimilars Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Biosimilars Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Biosimilars Market.
  • Evaluate the key vendors in the Biosimilars Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
      1. 360iResearch Market Share Analysis
      2. 360iResearch Competitive Strategic Window
  3. Executive Summary
    1. Market Outlook
    2. Indication Outlook
    3. Product Outlook
    4. Manufacturing Outlook
    5. Geography Outlook
    6. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Biosimilars Market, By Geography
  5. Market Dynamics
    1. Introduction
      1. Drivers
        1. Growing pressure to reduce healthcare expenditure
        2. Growing demands of pharmaceutical drugs
        3. Expiration of major patents during the forecast period
        4. Supportive government initiative and awareness creating programs in the developing economies
        5. Lower cost biosimilars drugs than original biologics
      2. Restraints
        1. Reluctance of physicians to prescribe biosimilars
        2. Unawareness among patients and preference for brand
      3. Opportunities
        1. New indications and patent expiry of biologic products
        2. Potential in emerging markets
        3. Emergence of bio-betters drugs
      4. Challenges
        1. Stringent regulatory requirements adversely affecting investment in the biosimilars market
        2. High investment required for research and development
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
      1. Technical Development & Trends
      2. Regulatory Submissions Timelines
      3. Clinical Bio Analytics and Technical Timelines and Related FTEs
      4. Drugs Loosing Patent: 2018-2022
  7. Global Biosimilars Market, By Indication
    1. Introduction
    2. Autoimmune Diseases
    3. Blood Disorders
    4. Chronic Diseases
    5. Growth Hormone Deficiency
    6. Infectious Diseases
    7. Oncology
  8. Global Biosimilars Market, By Product
    1. Introduction
    2. Recombinant Glycosylated Proteins
      1. Erythropoietin
      2. Follitropin
      3. Monoclonal Antibodies
        1. Adalimumab
        2. Infliximab
        3. Rituximab
    3. Recombinant Non-Glycosylated Proteins
      1. Granulocyte Colony-Stimulating Factor
      2. Insulin
      3. Interferons
        1. Interferon-Alpha
        2. Interferon-Beta
      4. Recombinant Human Growth Hormone
    4. Recombinant Peptides
      1. Calcitonin
      2. Glucagon
  9. Global Biosimilars Market, By Manufacturing
    1. Introduction
    2. Contract Manufacturing
    3. In-House Manufacturing
  10. Americas Biosimilars Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Biosimilars Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  12. Europe, Middle East & Africa Biosimilars Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  13. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. 360iResearch Market Ranking Analysis
    3. 360iResearch Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
  14. Company Usability Profiles
    1. AMEGA Biotech S.A.
    2. Amgen Inc.
    3. Apotex Inc.
    4. Biogen Inc.
    5. Biogen Inc.
    6. Biosidus S.A.
    7. Bioton S.A.
    8. Dr. Reddy's Laboratories Limited
    9. Dr. Reddy's Laboratories Limited
    10. Innovent Biologics, Inc.
    11. JHL Biotech, Inc.
    12. LG Chem, Ltd.
    13. Merck Sharp & Dohme Corp.
    14. Mylan N.V.
    15. Pfizer Inc.
    16. Sandoz International GmbH
  15. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL BIOSIMILARS MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  3. GLOBAL BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  4. GLOBAL BIOSIMILARS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL BIOSIMILARS MARKET SIZE, BY BLOOD DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL BIOSIMILARS MARKET SIZE, BY CHRONIC DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL BIOSIMILARS MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL BIOSIMILARS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL BIOSIMILARS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  11. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT GLYCOSYLATED PROTEINS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL BIOSIMILARS MARKET SIZE, BY ERYTHROPOIETIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL BIOSIMILARS MARKET SIZE, BY FOLLITROPIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL BIOSIMILARS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL BIOSIMILARS MARKET SIZE, BY ADALIMUMAB, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL BIOSIMILARS MARKET SIZE, BY INFLIXIMAB, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL BIOSIMILARS MARKET SIZE, BY RITUXIMAB, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT NON-GLYCOSYLATED PROTEINS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL BIOSIMILARS MARKET SIZE, BY GRANULOCYTE COLONY-STIMULATING FACTOR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL BIOSIMILARS MARKET SIZE, BY INSULIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  21. GLOBAL BIOSIMILARS MARKET SIZE, BY INTERFERONS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL BIOSIMILARS MARKET SIZE, BY INTERFERON-ALPHA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  23. GLOBAL BIOSIMILARS MARKET SIZE, BY INTERFERON-BETA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  24. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT HUMAN GROWTH HORMONE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  25. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT PEPTIDES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  26. GLOBAL BIOSIMILARS MARKET SIZE, BY CALCITONIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  27. GLOBAL BIOSIMILARS MARKET SIZE, BY GLUCAGON, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  28. GLOBAL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  29. GLOBAL BIOSIMILARS MARKET SIZE, BY CONTRACT MANUFACTURING, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  30. GLOBAL BIOSIMILARS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  31. AMERICAS BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  32. AMERICAS BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  33. AMERICAS BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  34. AMERICAS BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  35. ARGENTINA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  36. ARGENTINA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  37. ARGENTINA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  38. BRAZIL BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  39. BRAZIL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  40. BRAZIL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  41. CANADA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  42. CANADA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  43. CANADA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  44. MEXICO BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  45. MEXICO BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  46. MEXICO BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  47. UNITED STATES BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  48. UNITED STATES BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  49. UNITED STATES BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  50. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  51. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  52. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  53. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  54. AUSTRALIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  55. AUSTRALIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  56. AUSTRALIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  57. CHINA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  58. CHINA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  59. CHINA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  60. INDIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  61. INDIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  62. INDIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  63. INDONESIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  64. INDONESIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  65. INDONESIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  66. JAPAN BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  67. JAPAN BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  68. JAPAN BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  69. MALAYSIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  70. MALAYSIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  71. MALAYSIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  72. PHILIPPINES BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  73. PHILIPPINES BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  74. PHILIPPINES BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  75. SOUTH KOREA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  76. SOUTH KOREA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  77. SOUTH KOREA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  78. THAILAND BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  79. THAILAND BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  80. THAILAND BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  81. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  82. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  83. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  84. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  85. FRANCE BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  86. FRANCE BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  87. FRANCE BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  88. GERMANY BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  89. GERMANY BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  90. GERMANY BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  91. ITALY BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  92. ITALY BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  93. ITALY BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  94. NETHERLANDS BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  95. NETHERLANDS BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  96. NETHERLANDS BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  97. QATAR BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  98. QATAR BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  99. QATAR BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  100. RUSSIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  101. RUSSIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  102. RUSSIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  103. SAUDI ARABIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  104. SAUDI ARABIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  105. SAUDI ARABIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  106. SOUTH AFRICA BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  107. SOUTH AFRICA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  108. SOUTH AFRICA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  109. SPAIN BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  110. SPAIN BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  111. SPAIN BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  112. UNITED ARAB EMIRATES BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  113. UNITED ARAB EMIRATES BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  114. UNITED ARAB EMIRATES BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  115. UNITED KINGDOM BIOSIMILARS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  116. UNITED KINGDOM BIOSIMILARS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  117. UNITED KINGDOM BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2017-2025 (USD MILLION)
  118. GLOBAL BIOSIMILARS MARKET: SCORES
  119. GLOBAL BIOSIMILARS MARKET: BUSINESS STRATEGY
  120. GLOBAL BIOSIMILARS MARKET: PRODUCT SATISFACTION
  121. GLOBAL BIOSIMILARS MARKET: RANKING
  122. GLOBAL BIOSIMILARS MARKET: MERGER & ACQUISITION
  123. GLOBAL BIOSIMILARS MARKET: AGREEMENT, COLLABORATION & PARTNERSHIP
  124. GLOBAL BIOSIMILARS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  125. GLOBAL BIOSIMILARS MARKET: INVESTMENT & FUNDING
  126. GLOBAL BIOSIMILARS MARKET: EDITION DETAILS
  127. GLOBAL BIOSIMILARS MARKET: LICENSE DETAILS
  128. GLOBAL BIOSIMILARS MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL BIOSIMILARS MARKET: RESEARCH PROCESS
  2. GLOBAL BIOSIMILARS MARKET: RESEARCH EXECUTION
  3. GLOBAL BIOSIMILARS MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL BIOSIMILARS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  5. GLOBAL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
  6. GLOBAL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2019 VS 2025 (USD MILLION)
  7. GLOBAL BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOSIMILARS MARKET, BY TYPE
  9. GLOBAL BIOSIMILARS MARKET SIZE, 2017-2025 (USD MILLION)
  10. GLOBAL BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  12. GLOBAL BIOSIMILARS MARKET: MARKET DYNAMICS
  13. GLOBAL BIOSIMILARS MARKET: PORTERS FIVE FORCES ANALYSIS
  14. GLOBAL BIOSIMILARS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  16. GLOBAL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
  17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
  18. GLOBAL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2019 VS 2025 (USD MILLION)
  19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2025 (USD MILLION)
  20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  21. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  23. GLOBAL BIOSIMILARS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  1. AMEGA Biotech S.A.
  2. Amgen Inc.
  3. Apotex Inc.
  4. Biogen Inc.
  5. Biogen Inc.
  6. Biosidus S.A.
  7. Bioton S.A.
  8. Dr. Reddy's Laboratories Limited
  9. Dr. Reddy's Laboratories Limited
  10. Innovent Biologics, Inc.
  11. JHL Biotech, Inc.
  12. LG Chem, Ltd.
  13. Merck Sharp & Dohme Corp.
  14. Mylan N.V.
  15. Pfizer Inc.
  16. Sandoz International GmbH